학술논문
Cabozantinib plus Nivolumab Phase I Expansion Study in Patients with Metastatic Urothelial Carcinoma Refractory to Immune Checkpoint Inhibitor Therapy
Document Type
Article
Author
Girardi, D.M.; Niglio, S.A.; Nadal, R.; Cordes, L.; Ley, L.; Ortiz, O.S.; Cadena, J.; Diaz, C.; Costello, R.; Figg, W.D.; Ning, Y.-M.; Apolo, A.B.; Mortazavi, A.; Lara, P.; Pal, S.K.; Saraiya, B.; Bagheri, H.; Redd, B.; Steinberg, S.M.; Chan, K.S.; Lee, M.-J.; Lee, S.; Trepel, J.B.; Yu, Y.; Cao, L.; Gurram, S.; Chalfin, H.J.; Valera, V.; Bottaro, D.P.; Merino, M.; Toubaji, A.; Streicher, H.; Wright, J.J.; Sharon, E.; Parnes, H.L.
Source
In: Clinical Cancer Research . (Clinical Cancer Research, 1 April 2022, 28(7):1353-1362)
Subject
Language
English
ISSN
15573265
10780432
10780432